Clinical Trial Update: Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating dose individualization of antineoplastic and anti-infective drugs in children with hematological neoplasms; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Neoplasms

Snippet

Sponsor: Wei Zhao | Conditions: Hematological Neoplasms | Phase 4 | Status: RECRUITING